Dr. Comander's current research efforts are focused on studying patients with inherited retinal degenerations, including retinitis pigmentosa (RP), which is caused by genetic mutations inherited from one or both parents. Most people who suffer from RP typically experience a steady visual decline during their lifetime, with many patients becoming blind. The disease affects approximately 100,000 people in the U.S. and 2 million people worldwide.
A clinician scientist, Dr. Comander is a member of the Retina Service and the
"This research addresses a major challenge in understanding the mechanisms that underlie the pathology of inherited retinal disease, and will help us determine which gene misspellings in patients are disease-causing and which are benign," says Dr. Comander. "This is an important time in the field of inherited retinal degenerations, when early successes with gene therapy and molecular diagnostics need to be expanded and translated into broad clinical use."
Keywords for this news article include: Biotechnology, Genetics, Blindness, Gene Therapy, Bioengineering, Risk and Prevention,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- Chinese May Have Spotted Malaysia Airlines Debris
- First-time Jobless Claims Drop Unexpectedly
- Obama, Ukraine Discuss Russian Incursion in Crimea
- U.S. Business Inventories Up, Retail Sales Down
- 'Candy Crush' Maker Files IPO
- Why Buffett Bets Big on Green Energy
- Jay Z, Kanye Delight Fans With Two-Hour Set at SXSW
- First-time U.S. Jobless Claims Hit 3-month Low
- General Electric Plans IPO of Credit Card Unit
- Accused Killer Texted Son Moments Before Shooting Man for Texting: Prosecutors